New kidney protein speeds/improves the diagnosis of failing kidneys

Jun 03, 2008

Walk into any emergency department complaining of chest pain and you are likely to have blood drawn. Within hours it should be clear whether you've had a heart attack, based on enzyme levels in your blood and whether those levels reveal the tissue damage normally associated with a heart attack or other major cardiac event.

Walk into any emergency department with life-threatening kidney damage and the story is not quite the same. First, no test can reveal kidney damage in an efficient and timely way. Since the current check for kidney damage, a blood test for creatinine, can take longer than one or two days to accumulate in clinically significant levels, irreversible damage might already have set in during the time between injury and diagnosis.

Second, today's standard creatinine test does not indicate the cause of the damage: Could an elevated serum creatinine be acute kidney failure from an emergent medication reaction or an underlying infection, or could it be kidney disease that was previously active, but now dormant?

To tackle the gap between injury, diagnosis and treatment, a unique team of basic scientists, physicians, medical and college students is focusing on a small protein found in the urine at the time of sudden kidney failure. The protein detects kidney injury one to two days sooner than the creatinine test for renal failure. A simple urine test for the protein NGAL (neutrophil gelatinase-associated lipocalin) can help emergency department physicians more accurately and rapidly diagnose kidney failure, which can result in intensive care admission, dialysis, or even death. This fast and precise test will allow physicians to make evidence-based and potentially lifesaving treatment decisions.

The team, led by Jonathan Barasch, M.D., Ph.D., associate professor of medicine, and Thomas Nickolas, M.D. M.S., assistant professor of clinical medicine at Columbia University Medical Center, will publish the results of its study, conducted in the emergency department of NewYork-Presbyterian Hospital/Columbia University Medical Center, in the June 3 issue of the Annals of Internal Medicine.

If testing for NGAL is broadly implemented in emergency departments, doctors may be able to better distinguish between acute kidney injury that needs to be treated aggressively and chronic disease, which may not require an emergent treatment and is more common in many chronic illnesses, such as diabetes. Not adequately diagnosing a more severe problem can be life-threatening: Approximately 65 percent of patients with NGAL protein in the urine will require care by a nephrologist, another 32 percent will need dialysis, and 29 percent will require care in the intensive care unit, the study's authors have found.

"NGAL was diagnostic in a single test, whereas a single serum creatinine test can't discriminate acute kidney failure from chronic kidney disease," says Dr. Barasch, who found a connection between NGAL and the kidneys several years ago. "By showing that NGAL distinguishes acute kidney injury from other types of problems, this trial is a first step toward applying this protein to everyday clinical practice."

In their trial with more than 600 patients who came to the emergency department at NYP/Columbia, researchers found NGAL levels in patients later diagnosed with acute kidney failure were 30 times higher than patients who did not have renal injury.

"This level of accuracy is encouraging," said Pietro Canetta, M.D., a resident at NYP/Columbia who helped run the study at the emergency department. "Getting this quality of information so early in a patient's course, from just a single drop of urine, could be very helpful to clinicians. It provides concrete data in a clinical situation which is often dominated by guesswork and uncertainty."

Source: Columbia University

Explore further: Restrictions lifted at British bird flu farm

add to favorites email to friend print save as pdf

Related Stories

Privacy issues shadow medical apps' claims to improve care

Sep 02, 2013

Smartphones and tablets are go-to gadgets to count calories, document daily jogs, measure heart rates and record sleep patterns. Some applications now even analyze blood sugar levels, track fertility or monitor moods for ...

Nanosensors could aid drug manufacturing

Aug 16, 2013

MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs—especially those based on antibodies—more ...

Recommended for you

Restrictions lifted at British bird flu farm

9 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.